SleepHelsinki! CIRCADIAN SLEEP REGULATION IN ADOLESCENCE (SleepHel)

November 11, 2016 updated by: Anu-Katriina Pesonen, University of Helsinki

Sleep Helsinki! CIRCADIAN SLEEP REGULATION IN ADOLESCENCE

Adolescence associates with alterations in sleep-wake organization, such as later circadian phase preference. Simultaneously external pressures, such as evening-driven social activities increase. These may lead to delayed sleep phase, which may cause serious problems for waking up at socially accepted times, and absenteeism from the school may follow. This project aims at tracking risk factors for later circadian regulation problems, characterizing interconnections of biological, psychological and behavioural mechanisms that maintain or induce poor sleep regulation in adolescence, and building a cost-effective, theoretically-based sleep intervention for adolescents with delayed sleep phase. This randomized control trial capitalizes on a new population-based cohort of 16-17-year olds.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland
        • University of Helsinki

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Late bedtime several times per week

Exclusion Criteria:

  • Chronic disease that affects sleep. Ongoing therapeutic treatment relationship if considered overlapping by the participant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Control
Minimal information on sleep timing
Minimal information on sleep timing and advancing the sleep rhythm
EXPERIMENTAL: Psychoeducation
An extensive psychoeducational platform
An extensive information platform in the internet created for this purpose
EXPERIMENTAL: Bright light
Bright light treatment with 10 000 lux at max
Morning bright light 10 000 lux maximum duration 4-6 weeks
EXPERIMENTAL: Gamified intervention
A new gamified intervention designed for mobile phones
A new mobile application for assisting in sleep regulation, duration 4-6 weeks
Other Names:
  • Helsinki Sleep Factory
EXPERIMENTAL: Bright light and gamified intervention
A combination of the two
Morning bright light 10 000 lux maximum duration 4-6 weeks
A new mobile application for assisting in sleep regulation, duration 4-6 weeks
Other Names:
  • Helsinki Sleep Factory
EXPERIMENTAL: Sleep coaching
A new intervention protocol including a personified approach to solve problems and increase motivation for better sleep behavior
A new personalized program, duration 4-6 weeks
EXPERIMENTAL: Sleep coaching + bright light
A combination of the two
Morning bright light 10 000 lux maximum duration 4-6 weeks
A new personalized program, duration 4-6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Circadian sleep rhythm
Time Frame: 8 weeks
Actigraphy (brand GeneActiv)
8 weeks
Circadian body temperature rhythm
Time Frame: 8 weeks
iButton measurement from the wrist
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood
Time Frame: 8 weeks
Experience sampling method, brand Psymate
8 weeks
Insomnia symptoms
Time Frame: 8 weeks
Bergen Insomnia Scale
8 weeks
Sleep problems
Time Frame: 8 weeks
Pittsburgh Sleep Quality Index
8 weeks
Depression
Time Frame: 8 weeks
Beck Depression Inventory
8 weeks
Anxiety
Time Frame: 8 weeks
Generalized Anxiety Disorder questionnaire GAD-7
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anu-Katriina Pesonen, PhD, University of Helsinki

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (ANTICIPATED)

December 1, 2018

Study Completion (ANTICIPATED)

December 1, 2018

Study Registration Dates

First Submitted

November 9, 2016

First Submitted That Met QC Criteria

November 11, 2016

First Posted (ESTIMATE)

November 16, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

November 16, 2016

Last Update Submitted That Met QC Criteria

November 11, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder Circadian Rhythm, Delayed Sleep Phase Type

Clinical Trials on Control

3
Subscribe